CARON, Giulia

CARON, Giulia  

BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE  

Mostra records
Risultati 1 - 20 di 41 (tempo di esecuzione: 0.023 secondi).
Titolo Data di pubblicazione Autore(i) File
A computational strategy to predict recognition and catalysis on recalcitrant chlorinated substrates by a catechol1,2 dioxygenase. 2010 Cecilia Rosso; Giulia Caron; Giuseppe Ermondi; Carlo Giunta; Gianfranco Gilardi; Francesca Valetti
A free web application for sharing resources about cyclodextrin/ligand complexes 2008 Ermondi G; Esposito R; Caron G
A kinetic study of the interaction between potential photosensitizers and albumin 2013 Sonja Visentin ; Nadia Barbero; Guido Viscardi ; Giulia Caron ; Giuseppe Ermondi
A Molecular-Modeling Approach to Understanding the Contributions Made by Ionization and Lipophilicity to Drug Binding to Albumin 2004 G. Ermondi; M. Lorenti; G. Caron
A mucus model to evaluate the diffusion of drugs for more efficient cystic fibrosis therapies 2019 Pacheco DP, Butnarasu C, Bertoglio F, Suarez Vargas N, Briatico-Vangosa F, van Uden S, Visai L, Petrini P, Vallaro M, Caron G, Visentin S
Access of the substrate to the active site of yeast oxidosqualene cyclase: a modelling and site-directed mutagenesis approach 2009 S. Oliaro-Bosso; S. Taramino; Y. Ferrari; G. Ermondi; G. Caron; F. Viola; G. Balliano
Airway mucus microenvironment modelling to be applied on cystic fibrosis drug discovery 2017 Petrini, P; Pacheco, Dp; Pontremoli, C.; Caron, G.; Visentin, S
Application of in silico classical drug discovery tools for peptide research 2013 Ermondi, Giuseppe; Esposito, Roberto; Visconti, Alessia; Visentin, Sonja; Vallaro, Maura; Rinaldi, Laura; Caron, Giulia
APPLICATION OF IN-SILICO "CLASSICAL" DRUG DISCOVERY TOOLS TO PEPTIDE RESEARCH 2013 G. Ermondi; R. Esposito; A. Visconti; S. Visentin; M. Vallaro; L. Rinaldi; G. Caron
BR ANALYSIS: A TOOL TO UNRAVEL MOLECULAR INTERACTIONS BALANCE 2016 Ermondi, Giuseppe; Vallaro, Maura; Caron, Giulia
Cyanoacrylate nanospheres and nanocapsules containing lipophilic prodrugs of gemcitabine 2003 B. Stella; F. Rocco; M.L. Immordino; S. Arpicco; G. Caron; F. Dosio; M. Ceruti; L. Cattel
Docking strategies for the prediction of complex stability constant (log K) for 1:1 inclusion complexation of chemicals with ß-CD 2006 G. Caron; G. Ermondi
Experimental and computational studies of intramolecular hydrogen bonding (IMHB) in medicinal chemistry 2011 Shalaeva M.; Caron G.; Yalamanchi K.; Farley K.; O'Connell T.; Abramov Y.; Plummer M.; Che L.; Philippe L.; Shapiro M.
Experimental determination and modeling of the lipophilicity in platinum complexes 2011 Mauro Ravera; Elisabetta Gabano; Giuseppe Ermondi; Giulia Caron; James A. Platts; D. Osella
Experimental validation of in silico methods to predict the recognition properties of active sites: the test-case of a non-heme iron dioxygenase 2011 Valetti F; Rosso C; Garrone A; Caron G; Ermondi G; Gilardi G
Exploring the access of the substrate to the active site of yeast oxidosqualene cyclase by site-directed mutagenesis 2007 S. Oliaro-Bosso; S. Taramino; I. Ferrari; G. Ermondi; G. Caron; F. Viola; G. Balliano
Exploring the access of the substrate to the active site of yeast oxidosqualene cyclase by site-directed mutagenesis. 2007 S. Oliaro-Bosso; S. Taramino; I. Ferrari; G. Ermondi; G. Caron; F. Viola; G. Balliano
Glycosylated prodrugs of oxines for enzyme-specific activation in targeted cancer therapy 2012 Oliveri V.; Viale M.; Caron G.; Aiello C.; Vecchio G.
HT Caco-2 permeability: the dominant role played by solutes’ hydrogen bonding donor properties 2015 T. Potter;G. Ermondi;G. Newbury;G. Caron
HTS Assay Development: an airway mucus microenvironment modelling to be applied on cystic fibrosis drug discovery 2017 Petrini, P.; Pacheco, D.; Visai, L.; Coletti, M.; Bertoglio, F.; Caron, G.; Visentin, S.